We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 12.51 | 29.0930232558 | 43 | 55.51 | 15.3 | 524954 | 30.67081059 | CS |
4 | 9.01 | 19.376344086 | 46.5 | 55.51 | 15.3 | 218943 | 35.89636983 | CS |
12 | 10.04 | 22.0804926325 | 45.47 | 55.51 | 15.3 | 141777 | 41.46707518 | CS |
26 | 37.18 | 202.836879433 | 18.33 | 55.51 | 15.3 | 114107 | 36.09822284 | CS |
52 | 38.61 | 228.461538462 | 16.9 | 55.51 | 15.0001 | 100881 | 34.99737709 | CS |
156 | 38.61 | 228.461538462 | 16.9 | 55.51 | 15.0001 | 100881 | 34.99737709 | CS |
260 | 38.61 | 228.461538462 | 16.9 | 55.51 | 15.0001 | 100881 | 34.99737709 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions